Literature DB >> 20648422

[Problems and complications of surgical techniques for treatment of full-thickness cartilage defects].

P Niemeyer1, W Koestler, N P Südkamp.   

Abstract

AIM: There has been great progress concerning the surgical treatment of full-thickness cartilage defects within recent years. Surgical techniques such as arthroscopic microfracturing (MF), autologous osteochondral transplantation (OCT) and autologous chondrocyte implantation (ACI) have been introduced and, by using these techniques, reliable and satisfying clinical results can be achieved. Nevertheless, there are also technique-related problems and characteristic complications of all surgical techniques in the field of cartilage repair. Knowledge of these complications is essential for every surgeon using these techniques. The aim of the present article is to give an overview concerning technique-associated and characteristic complications of the most common cartilage repair techniques including arthroscopic microfracturing, autologous osteochondral transplantation and autologous chondrocyte implantation (ACI).
METHODS: In order to identify relevant literature concerning complications following cartilage repair, medical databases including "medline", "ovid" and "web of science" were searched for the terms "autologous chondrocyte implantation", "autologous chondrocyte transplantation", "microfracture", "osteochondral transplantation", "cartilage repair", "cartilage defect" and "complications" in October 2009. The present publication represents a non-systematic review including publications which were considered relevant for describing charateristic complications and adverse events in surgical techniques used for cartilage repair.
RESULTS: Although the number of studies describing complications and adverse events following surgical cartilage repair studies is limited, for all techniques included in the present review (arthroscopic microfracturing, autologous osteochondral transplantation and autologous chondrocyte implantation) technique-associated and characteristic complications could be identified. While regenerative tissue following microfracturing seems to be limited in terms of durability, intralesional bone formation and elevation of the subchondral bone plate seem to be characteristic problems of this technique. Harvest morbidity, degeneration of the surrounding cartilage, necrosis of the transplanted cylinders and a lack of integration of the cartilage into the surrounding cartilage seem to be related to the transplantation of osteochondral cylinders (OATS/OCT), while hypertrophic regenerative cartilage, disturbed fusion into the adjacent cartilage, delamination and insufficient cartilage regeneration are associated with the autologous chondrocyte implantation (ACI).
CONCLUSION: The present paper identifies technique-associated complications for the most common surgical techniques used for cartilage repair. Even if the clinical relevance of the complications described in the current article has not been investigated to its fullest extent, the awareness of these characteristic complications is essential in order to avoid them whenever possible or to develop standardised treatment regimes for these problems. This needs to be addressed in further investigations. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2010        PMID: 20648422     DOI: 10.1055/s-0030-1250104

Source DB:  PubMed          Journal:  Z Orthop Unfall        ISSN: 1864-6697            Impact factor:   0.923


  11 in total

1.  [Therapeutic utilization of stem cells in orthopedics].

Authors:  C Chiari; S Walzer; D Stelzeneder; M Schreiner; R Windhager
Journal:  Orthopade       Date:  2017-12       Impact factor: 1.087

2.  [Operative treatment of cartilage lesions].

Authors:  A Rauch; E Rembeck; L Kohn
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

3.  Reoperative characteristics after microfracture of knee cartilage lesions in 454 patients.

Authors:  G M Salzmann; B Sah; N P Südkamp; P Niemeyer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-04-08       Impact factor: 4.342

4.  Reviewing subchondral cartilage surgery: considerations for standardised and outcome predictable cartilage remodelling: a technical note.

Authors:  Jan P Benthien; Peter Behrens
Journal:  Int Orthop       Date:  2013-08-06       Impact factor: 3.075

5.  Is the transplant quality at the time of surgery adequate for matrix-guided autologous cartilage transplantation? A pilot study.

Authors:  Johannes Zellner; Peter Angele; Florian Zeman; Richard Kujat; Michael Nerlich
Journal:  Clin Orthop Relat Res       Date:  2013-09       Impact factor: 4.176

6.  Vitamin E protects chondrocytes against hydrogen peroxide-induced oxidative stress in vitro.

Authors:  Fazal-Ur-Rehman Bhatti; Azra Mehmood; Nadia Wajid; Mohammad Rauf; Shaheen N Khan; Sheikh Riazuddin
Journal:  Inflamm Res       Date:  2013-05-31       Impact factor: 4.575

Review 7.  [Cell-based therapy options for osteochondral defects. Autologous mesenchymal stem cells compared to autologous chondrocytes].

Authors:  S Grässel; S Anders
Journal:  Orthopade       Date:  2012-05       Impact factor: 1.087

8.  Clinical outcome and T2 assessment following autologous matrix-induced chondrogenesis in osteochondral lesions of the talus.

Authors:  Eva Johanna Kubosch; Benjamin Erdle; Kaywan Izadpanah; David Kubosch; Markus Uhl; Norbert P Südkamp; Philipp Niemeyer
Journal:  Int Orthop       Date:  2015-09-08       Impact factor: 3.075

9.  Maintenance of "stem cell" features of cartilage cell sub-populations during in vitro propagation.

Authors:  Karin Benz; Claudia Stippich; Christian Freudigmann; Juergen A Mollenhauer; Wilhelm K Aicher
Journal:  J Transl Med       Date:  2013-01-30       Impact factor: 5.531

10.  Arthroscopic fixation of cell free polymer-based cartilage implants with a bioinspired polymer surface on the hip joint: a cadaveric pilot study.

Authors:  Matthias Lahner; Christian Duif; Andreas Ficklscherer; Christian Kaps; Lukas Kalwa; Tobias Seidl
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.